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Yun-fei Duan1, Yan Tan2, Bo Yuan3 and Feng Zhu1*Abstract
Background: Small cell neuroendocrine carcinoma of the maxillary sinus, a rare malignant tumor, has a poor prognosis
because of its high incidence of metastasis. Moreover, metastatic cancer-induced hepatic rupture, characterized
by hemoperitoneum, is infrequent, although several lines of evidences have reported that a wide variety of other
neoplasms can cause this usually fatal manifestation.
Case presentation: We now present the first case of a 49-year-old man with spontaneous rupture of hepatic
metastasis from small cell neuroendocrine carcinoma of the maxillary sinus and ultimately resulted in massive
intraperitoneal bleeding, which was successfully controlled by subsequent surgery (partial hepatectomy). The
postoperative clinical manifestation of the patient was uneventful. He was discharged on the 16th day after operation
and without any complication.
Conclusions: Small cell neuroendocrine carcinoma of the maxillary sinus is very scarce and unfortunately has a poor
prognosis. It has potential to cause spontaneous metastatic rupture which can elicit fatal hemorrhage. Emergency
surgery is effective, although the long-term outcome is still unsatisfactory.
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Small cell neuroendocrine carcinoma of maxillary sinus is
a rare and aggressive malignant disease. Non-traumatic
rupture of the liver frequently occurred in primary benign
or malignant tumors, metastatic carcinoma, peliosishepa-
tis, polyarteritisnodosa, systemic lupus erythematosus, and
toxemia of pregnancy [1]. However, spontaneous hepatic
rupture induced by metastatic cancer, which presented
as hemoperitoneum, is not common [2]. We currently
reported a patient with hemoperitoneum due to bleeding
hepatic metastasis which was originated from small
cell neuroendocrine carcinoma of the maxillary sinus,
although there is no literature reporting it.
Case presentation
A 49-year-old man had undergone surgery to resect a
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reproduction in any medium, provided the orupper maxillary sinus 21 months previously (Figure 1).
He underwent preoperative ‘pingyangmycin’10 days of
chemotherapy. The patient complained about persistent
and severe right upper quadrant pain which lasted about
6 hours.
We observed that he had a pale complexion and dis-
tended, tender abdomen after careful physical examina-
tions. The vital signs were a temperature of 36.8°C, blood
pressure of 90/55 mmHg, and pulse rate of 130/min.
The hematological data were as follows: white blood cell
(WBC) count 12.4 × 103/mL (3.5 × 103/mL-9.5 × 103/mL),
hemoglobin 80 g/L (130-175 g/L), hematocrit 0.233 (0.4-
0.5), platelets 161 × 103/mL (125 × 103/mL-350 × 103/mL),
and prothrombin time (PT) 13.3 s (9-13 s). The hepatic
function data were as follows: alanine aminotransferase
(ALT) 98 U/L (9-50U/L), aspartate transaminase (AST)
15 U/L (15-40U/L), γ-glutamyltranspeptidase (γ-GTP)
164 U/L (10-60U/L), total protein 56.6 g/L (60-82 g/L),
and total bilirubin 9.6 μmol/L (4-19 μmol/L). Markers for
hepatitis viruses except for hepatitis B surface antibodytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 The specimen of the maxillary sinus carcinoma (A) and it’s HE staining (B). The tumors are composed of small-sized regular cells
which are arranged in broad sheets, nests, and cords.
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carcino-embryonalantigen (CEA) were slightly increased.
Additionally, serum levels of carbohydrate-antigen 19-9
(CA19-9), neurone-specific enolase (NSE), alpha-fetoprotein
(AFP), cytokeratin 19 fragment (CY211), carbohydrate-
antigen 125 (CA125), carbohydrate-antigen 724 (CA724),
prostate-specific antigen (PSA), and squamous cell car-
cinoma (SCC) were totally at normal levels (Table 1).
Abdominal ultrasonography showed that isolated lesion
corresponded to blood on diagnostic puncture in the
liver and ascites. Computed tomography (CT) scan showed
a large tumor in the right lobe of the liver and with an adja-
cent intraperitoneal hyperdense fluid collection (Figure 2).
Besides, there was no underlying cirrhosis. Furthermore,
CT scan revealed no abnormity in both lungs. We consid-
ered that the tumor was resectable which was based on
the results of CT scan and liver function.
After fast-track resuscitation (4 units of packed red
blood cells (600 mL) and 1,000 mL hetastarch 130/0.4
hydroxyethyl starch), the hemodynamics of the patientTable 1 Tumor markers of the patient
Parameter Patient Normal range
CEA (ng/mL) 6.77 0.00-5.00
CA19-9 (U/mL) 21.71 0.00-37.00
AFP (ng/mL) 3.04 0.00-8.00
NSE (ng/mL) 0.9 0.00-16.30
CA125 (U/mL) 9.60 0.00-35.00
CA724 (U/mL) 0.2 0.00-6.90
CY211 (ng/mL) 3.16 0.10-3.30
PSA (ng/mL) 0.56 0.00-4.00
SCC (ng/mL) 0.1 0.00-1.50became relatively stable. Moreover, 2,500 mL of blood
with clots were observed in the abdominal cavity in the
operation. The liver tissue of the patient showed a nor-
mal color and a smooth surface in appearance, but
there was an isolated lesion in segment 6 with a 6 cm
laceration of the capsule, which skeptically was malignant
tumor from macroscopical observation. There were no
other observed bleeding sites. A resection of segment 6 of
the liver was performed.
The resected tumor was 8 × 7 × 6.5 cm in size. The
immunohistochemisty findings were as follows: Hepatocyte
(-), CK5/6 (-), CK34 (-), P63 (-), CK8/18 (+), Vimentin (-),
CK35 (+), Ki-67 proliferation index was more than 70% (+).
Combined with the observation of HE staining (Figure 3),
microscopic examination of the tumor confirmed a meta-
static poorly differentiated carcinoma. Repeated immuno-Figure 2 CT reveals a large tumor (arrows) in the right lobe of
the liver along with an adjacent intraperitoneal hyperdense fluid
collection (black asterisk).
Figure 3 The hepatic tumors are composed of small-sized regular
cells which are arranged in broad sheets, nests, and cords. Many
of the cells contain cribriform nuclei with a fine reticular chromatin
pattern and small amounts of cytoplasm.
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and metastatic hepatic carcinoma showed that Hepatocyte
(-), CgA(-), CD56(+), Syn(+) (Figure 4). Ultimately, we
diagnosed and defined as hepatic metastases from small
cell neuroendocrine carcinoma of maxillary sinus.
The patient was discharged on the 16th day after
surgery and without any complication. He declined
chemotherapy and died of cachexia and pulmonary
metastasis after 7 months without the incidence of
recurrent hemoperitoneum.Discussion
Small cell neuroendocrine carcinoma of the sinonasal
region is not common of the sinonasal carcinomas with
neuroendocrine differentiation [3]. The histogenesis of
the neuroendocrine differentiated tumors is not clear.
It has been postulated that, outside the lung, this tumor
is derived from the neuroendocrine amine precursor
uptake decarboxylase (APUD) cells, which are widely
distributed in the body. The tumors are composed of
small-sized regular cells which are arranged in broad
sheets, nests, and cords. Many of the cells contain
cribriform nuclei with a fine reticular chromatin pat-
tern and small to moderate amounts of cytoplasm [4].
Immunohistochemical observation is essential to make
a pathological diagnosis. SNEC has been reported to
stain strongly with synaptophysin and CD56 nerve cell
adhesion molecule and weakly with chromogranin A
and CAM 5.2/AE-1 [5]. The prognosis in cases of head
and neck SNEC is very poor because of its high metastatic
rate [6]. In this patient we reported, the tumor metasta-
sized to the liver 21 months after maxillectomy.
Metastatic disease of the liver resulting in spontaneous
hepatic rupture is rare as compared with primary hepatictumor [2,7]. This probably reflects the tendency of meta-
static cancer to be less vascular and invasive, and to
penetrate the liver capsule less frequently than primary
tumor [7]. A recent study reviewed that there have some
reported cases of spontaneous rupture of hepatic metas-
tases from primary sites including the prostate, lung,
esophagus, stomach, kidney, colon, pancreas, testicle, gall-
bladder, skin, choriocarcinoma, malignant melanoma,
nasopharynx, and others [7-20]. But there was no report
regarding rupture of hepatic metastases from SNEC of
the maxillary sinus.
The typical presentation is sudden epigastric or right
hypochondria pain. Shock could be observed in some
patients, while most patients were manifested with
peritonitis or abdominal distension. Some patients are
paracentesis-positive with blood-stained ascites. Ultra-
sonography, a simple, quick, non-invasive investigating
method, can locate the ruptured tumor and reveal a free
intraperitoneal blood collection. CT scan is invaluable for
diagnosis and treatment planning because it can check the
severity of the cirrhosis and locate the tumor.
Rupture of a hepatic metastasis frequently results in
massive hemoperitoneum, which may be a terminal event
[21]. For these patients, it is therefore crucial to control
the bleeding and restore the blood pressure as soon as
possible. Transcatheter hepatic arterial embolization
(TAE) may seem to be ideal for these patients, since it
avoids general anesthesia to stop the bleeding without
operation [22], but it also has some demerits, including
recurrent bleeding and liver failure [22,23], peritoneal
abscess [24], and implanted metastases [25,26]. Further-
more, long-term results are poor if it is used as a sole
treatment approach [27], and it is not applicable when
the main trunk of the portal vein is obstructed. In
addition, a two-stage surgical operation (that is, TAE
followed by liver resection) would inevitably increase
the hospital stay and the cost. For our patients, one-stage
hepatectomy is still a good treatment method for those
who are stable hemodynamically and has a reasonable
liver function as well as the lesion is peripherally located.Conclusions
Small cell neuroendocrine carcinoma of the maxillary
sinus is very rare and has a poor prognosis. It may cause
spontaneous metastatic rupture which resulted in fatal
hemorrhage. Emergency surgery is effective but the out-
come is still unsatisfactory.Consent
Written informed consent was obtained from the patient’s
son for publication of this report and any accompanying
images.
Figure 4 Maxillary sinus carcinoma and metastatic hepatic carcinoma stained negative for Hepatocyte (A,E) and CgA (B,F), while
positive for CD56 (C,G) and Syn (D,H).
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